Related Experiment Video

Updated: May 26, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Therapeutic additions and possible deletions in oncology in 2011

S A Holstein1, R J Hohl

  • 1Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

Clinical Pharmacology and Therapeutics
|December 20, 2011
PubMed

Insights

The US Food and Drug Administration (FDA) approved six new cancer agents in 2011, a significant increase reflecting scientific advances. This rapid pace highlights progress in cancer therapeutics and drug approval processes.

Area of Science:

  • Oncology
  • Pharmacology
  • Regulatory Science

Background:

  • Cancer treatment approvals by the US Food and Drug Administration (FDA) were limited between 2008-2010.
  • Recent scientific advancements have accelerated the development and approval of novel cancer therapies.

Purpose of the Study:

  • To discuss newly approved cancer agents.
  • To analyze the unprecedented rate of new drug approvals.
  • To examine the role of the FDA's accelerated approval process.

Main Methods:

  • Review of FDA approval data for cancer agents.
  • Historical comparison of approval rates.
  • Analysis of key milestones in cancer drug development.

Main Results:

  • Six new chemical entities for cancer treatment were approved by the FDA in the first nine months of 2011.
  • This approval rate is unprecedented compared to the 2008-2010 period.
  • Milestones include the first monoclonal antibody (rituximab) in 1997 and targeted tyrosine kinase inhibitor (imatinib) in 2001.

Conclusions:

  • The current pace of cancer drug approval is historically high.
  • Advances in targeted therapies and biologics are driving this trend.
  • The FDA's accelerated approval pathway plays a crucial role.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...